Marjon Pasmooij, is head of the Science Department at the Dutch Medicines Evaluation Board (MEB), Associate Professor Drug Regulatory Science at Utrecht University, and co-chair of the Regulatory Science Network Netherlands (RSNN). Marjon studied Cell Biology in Wageningen, and did her PhD at the Dermatology Department of the University Medical Center Groningen on a rare genetic skin disease. Marjon has been employed by the MEB in various roles since 2007. She worked as a clinical assessor for 10 years in the field of gynaecology and dermatology. Since 2018 she heads the Science Department, and coordinates the Regulatory Science activities where the MEB is involved in (about 15 PhD projects, and 20-25 Master students yearly). She is also part of the EMA-HMA EU-Innovation Network, which facilitates the development of innovative medicines and associated technologies and aims to strengthen engagement with innovators, and a member of the Therapies Scientific Committee of the International Rare Diseases Research Consortium (IRDiRC). Together with Anneliene Jonker, Marjon co-led the IRDiRC Task Force on the Drug Repurposing Guidebook (https://orphandrugguide.org/).
